Pfizer COVID Vaccine 90 Percent Effective in Trials, Company May Request Approval by End of November
FEATURES
- Angels with Noses: A Theology of Toast by Patrick D. Degn
- What a Country Club Dinner Taught Me About Greatness by Becky Douglas
- For Valentine’s Day: Why is Christ Called the Bridegroom? by Robert Starling
- Elder Clark G. Gilbert Called as Newest Apostle by Meridian Church Newswire
- Do Parents really have a Favorite Child? Here’s what New Research from BYU says by BYU Media Relations
- Is Abraham the Most Pivotal Figure in History?—Come Follow Me: Abraham 1,2; Genesis 11-18 by Scot and Maurine Proctor
- Dallin H. Oaks Invites Latter-day Saints to Come Closer to Jesus Christ by Meridian Church Newswire
- Why a God of Order Would Ask Us to Take On the Chaos of Motherhood by Michaela Proctor Hutchins
- Painting the Portrait of Ancestors – Bringing a Dull Canvas to Life by Tanya Neider
- How Big Will the Salt Lake Temple Open House Be? by Deseret News
















Comments | Return to Story
Pauline HarryNovember 13, 2020
No long-term safety has been proven in this 2-month trial. The study reports only .02% of the study group from ALL OVER THE WORLD which doesn’t take into account how many cases are there are there, nutrition, weather, or lifestyle. And now they’re ready to start vaccinating millions! Throw tons of money at it and see if anyone sticks around?
Pauline HarryNovember 12, 2020
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial. Could end up helping to spread the virus.
ADD A COMMENT